Manufacturing Committee

The focus of the Manufacturing Committee is to build relationships between biopharmaceutical manufacturing professionals through peer-to-peer collaboration via BioNJ Membership, and to educate and inform the New Jersey life sciences community on all aspects of the manufacturing of biopharmaceuticals to facilitate scientific and medical advancement. Committee members participate in planning an annual Manufacturing Briefing.

Committee Members

PendoTECH – Jim Furey, President & CEO
Ulteemit BioConsulting, LLC – Michiel Ultee, Ph.D., Principal

Aprecia Pharmaceuticals, LLC – Jae Yoo, MBA, Ph.D., Chief Technology Officer
Chemical & Pharmaceutical Solutions – James Bruno, MBA, Ph.D., Managing Director
Hovione, LLC – Jim Streemke, Head of Chemical Operations
IVERIC bio, Inc. – Keith Westby, MBA, MSc, COO
Legend Biotech – John Tomtishen, Director of Manufacturing, CMC Technical Operations
McKinsey & Company – Andrea Gennari, Partner
McKinsey & Company – Katie Kelleher, MBA, Associate Partner
New Jersey Institute of Innovation (NJII) – Haro Hartounian, Ph.D., Senior Vice President, BioPharma Innovation
Reed Smith LLP – Betty Yan, MBA, JD, Partner
Rutgers, The State University of New Jersey  – Doug Hausner, PhD, Associate Director for Industrial Relations & Business Development
Rutgers, The State University of New Jersey – Fernando Muzzio, Ph.D., Director, NSF ERC on Structured Organic Systems
Rutgers, The State University of New Jersey – Vincent Smeraglia, JD, Executive Director, Office of Research Commercialization
Rutgers, The State University of New Jersey – Ravendra Singh, Ph.D., Assistant Research Professor
Sanofi – Bob Huang, PhD, Head of US CMC External Collaborations
Troutman Pepper Hamilton Sanders LLP – Tim Atkins, JD, Partner